Detalles de la búsqueda
1.
Tumor-Derived Extracellular Vesicles as a Novel Source of Protein Biomarkers for Cancer Diagnosis and Monitoring.
Proteomics
; 19(1-2): e1800155, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30467990
2.
Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma.
JCO Precis Oncol
; 7: e2200113, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36652664
3.
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
Eur J Cancer
; 172: 367-386, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35839732
4.
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.
JCO Precis Oncol
; 6: e2100534, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36265118
5.
Dynamic Landscape of Extracellular Vesicle-Associated Proteins Is Related to Treatment Response of Patients with Metastatic Breast Cancer.
Membranes (Basel)
; 11(11)2021 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34832109
6.
Comparison of Circulating Tumour DNA and Extracellular Vesicle DNA by Low-Pass Whole-Genome Sequencing Reveals Molecular Drivers of Disease in a Breast Cancer Patient.
Biomedicines
; 9(1)2020 Dec 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33375577
7.
Detection of BRAF splicing variants in plasma-derived cell-free nucleic acids and extracellular vesicles of melanoma patients failing targeted therapy therapies.
Oncotarget
; 11(44): 4016-4027, 2020 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33216826
Resultados
1 -
7
de 7
1
Próxima >
>>